Charter Hall FY26 slides: record $6.7bn inflows, shares fall 8%

Charter Hall Group (ASX:CHC) reported FY26 operating earnings of $488.1m (103.2c per security), up 26.8% YoY, alongside 26.4% return on contributed equity and 17% growth in property investment EBITDA. Despite the strong results, shares fell 7.89% to $20.36, with the market citing premium valuation (P/E 35.28) and a cautious view on near-term growth sustainability. FY27 guidance calls for 114.0c operating earnings (+10.5%) and 53.7c distributions (+6%), noting guidance excludes performance fees (upside if earned), while gearing rose to 14.2% from 6.0%.

Analysis

The market reaction looks more like a multiple reset than a read-through on fundamentals. For a platform business like CHC, the real earnings engine is not current occupancy but the conversion of fresh mandates and acquisitions into recurring fees and seed capital; that makes the record inflow number more important than the reported operating beat. If those flows persist, the next leg of upside should come from higher FUM, more transaction throughput, and optionality from performance fees—not from one-year EPS alone.

Second-order, this is constructive for the highest-quality asset pools and damaging for secondary owners. Capital is still paying up for modern logistics, convenience, and socially defensive assets, while older office stock and weaker balance sheets should face continued valuation lag and harder refinancing economics. In the listed space, that argues for relative outperformance of platform-heavy names versus office-heavy REITs and funds that need external equity to grow.

The main risk is valuation compression: at a premium multiple, CHC needs uninterrupted flow momentum and clean FY27 execution to justify the rating. What would break the thesis is any evidence of slowing institutional commitments, a guidance reset below the current growth path, or cap-rate re-widening if rates stay sticky. The contrarian view is that the selloff may be overdone if investors are underestimating the embedded upside from excluded performance fees and a more favorable rate backdrop over the next 6 to 18 months.

Key Decisions for Investors

• Do not chase the gap-down in CHC; wait 1-3 weeks for post-result digestion and only buy if the stock stabilizes while flow commentary remains intact. Falsifier: any indication of weaker FY27 commitments or a downgrade below the current earnings trajectory.
• Relative-value long CHC / short office-heavy REIT exposure (DXS or a basket of DXS, MGR) for 1-3 months. Thesis: capital is rewarding modern, high-occupancy platforms while secondary office remains structurally challenged.
• Overweight industrial/logistics beta via GMG over office beta for 6-12 months. CHC’s results reinforce that scarce, lease-sticky industrial assets still get repriced first when institutional money is active.
• Set an alert on any performance-fee commentary or a second major fundraise. If CHC converts that optionality, the stock can re-rate; if not, the current premium multiple is vulnerable to further compression.